The intraperitoneal neutralisation of IL-17A exerts protective effects against sepsis-induced organ tissue damage and lethality, which are associated with substantially reduced levels of bacteraemia and significant reductions in systemic proinflammatory cytokines. The gene discussed is IL17A; the disease is Sepsis.